Leqembi approved for use in Australia
The Therapeutic Goods Administration has registered a new amyloid-lowering therapy for adult patients with mild cognitive impairment due to Alzheimer’s...
Professionals with Alzheimer’s Global
The Therapeutic Goods Administration has registered a new amyloid-lowering therapy for adult patients with mild cognitive impairment due to Alzheimer’s...
Advertisement